Company Filing History:
2 out of 289 
1 out of 2,106 
Years Active: 2023-2025
Title: The Innovations of Adam S. Dingens
Introduction
Adam S. Dingens is an accomplished inventor based in Seattle, WA. He holds 2 patents that focus on advancements in viral protein research and therapeutic treatments. His work has significant implications for understanding and combating viral resistance.
Latest Patents
Dingens' latest patents include the development of cell-stored barcoded deep mutational scanning libraries. These libraries are designed to map resistance mutations to therapeutic treatments. They can predict which viruses may become resistant to therapeutic compounds and identify those that could evolve to infect new species. Additionally, these libraries facilitate the safe study of dangerous viruses that typically require high safety biocontainment facilities. They incorporate features that streamline data collection and assessment, overcoming many limitations of previous methods. Another notable patent involves barcoded influenza viruses and deep mutational scanning libraries. This innovation allows for the creation of barcoded influenza viruses without disrupting the function of viral proteins or the proper packaging of viral genome segments. These barcoded viruses can also be utilized to map influenza resistance mutations to therapeutic treatments.
Career Highlights
Dingens has worked with prestigious institutions such as the Fred Hutchinson Cancer Center and the University of Washington. His contributions to the field of virology and therapeutic research have been recognized for their potential to enhance our understanding of viral behavior and treatment efficacy.
Collaborations
Some of his notable collaborators include Jesse Bloom and Allison Greaney. Their joint efforts have further advanced the research in viral protein studies and therapeutic applications.
Conclusion
Adam S. Dingens is a significant figure in the field of virology, with his innovative patents paving the way for future research and therapeutic strategies. His work continues to impact the scientific community and enhance our understanding of viral resistance.